|
Endpoint
|
Overall
|
ADAPT
|
SAVE
|
p Value
|
|---|
|
First-pass mTICI ≥2b
|
48.5%
|
33.3%
|
59.6%
|
0.019
|
|
Carotid T
|
27.3%
|
11.5%
|
41.4%
|
0.323
|
|
M1 segment
|
57.4%
|
41.7%
|
67.2%
|
0.361
|
|
M2 segment
|
63.6%
|
60.0%
|
66.7%
|
1
|
|
First-pass mTICI ≥2c
|
27.5%
|
16.7%
|
35.4%
|
0.171
|
|
Carotid T
|
16.4%
|
0.0%
|
31.0%
|
0.038
|
|
M1 segment
|
36.2%
|
30.6%
|
39.7%
|
1
|
|
M2 segment
|
18.2%
|
10.0%
|
25.0%
|
1
|
|
Device-passes (Median, IQR)
|
–
|
2, 2–3
|
1, 1–2
|
< 0.001
|
|
Carotid T
|
–
|
3, 2–5
|
2, 1–3
|
< 0.001
|
|
M1 segment
|
–
|
2, 1–3
|
1, 1–2
|
0.133
|
|
M2 segment
|
–
|
1, 1–2
|
1, 1–2
|
1
|
|
ENT
|
12 (7)
|
9 (12.5)
|
3 (3)
|
0.570
|
|
Carotid T
|
6 (10.9)
|
6 (23.1)
|
0 (0)
|
0.152
|
|
M1 segment
|
5 (5.3)
|
3 (8.3)
|
2 (3.4)
|
1
|
|
M2 segment
|
1 (4.5)
|
0 (0)
|
1 (8.3)
|
1
|
|
mRS on 90 d (Median, IQR)
| |
3, 2–5
|
3, 1–6
|
1
|
|
Post interventional SAB
|
27 (15.8)
|
15 (20.8)
|
12 (12,1)
|
1
|
|
sICH
|
8 (4.8)
|
3 (4.2)
|
5 (5.2)
|
1
|
- ENT embolies to new territory, IQR interquartile Range, mRS modified Rankin Scale, sICH symptomatic intracranial hemorrhage
